日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

关于COVID-19抗病毒药物尼马替利韦/利托那韦(Paxlovid)与合并用药之间药物相互作用的管理建议

Marzolini, Catia; Kuritzkes, Daniel R; Marra, Fiona; Boyle, Alison; Gibbons, Sara; Flexner, Charles; Pozniak, Anton; Boffito, Marta; Waters, Laura; Burger, David; Back, David J; Khoo, Saye

Dexamethasone is a dose-dependent perpetrator of drug-drug interactions: implications for use in people living with HIV

地塞米松是一种剂量依赖性的药物相互作用剂:对艾滋病毒感染者用药的影响

Jacobs, Tom G; Marzolini, Catia; Back, David J; Burger, David M

The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics

寻找SARS-CoV-2/COVID-19治疗方法的艰辛之路

Siccardi, Marco; Schapiro, Jonathan; Di Perri, Giovanni; Back, David J

Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART

基于生理药代动力学模型预测左炔诺孕酮避孕植入剂与依非韦伦类抗逆转录病毒疗法之间药物相互作用中剂量调整的影响

Roberts, Owain; Rajoli, Rajith K R; Back, David J; Owen, Andrew; Darin, Kristin M; Fletcher, Courtney V; Lamorde, Mohammed; Scarsi, Kimberly K; Siccardi, Marco

Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma

开发、验证和应用一种高灵敏度的液相色谱-串联质谱法(LC-MS/MS)定量分析人血浆中皮下植入剂释放的左炔诺孕酮

Cirrincione, Lauren R; Penchala, Sujan Dilly; Scarsi, Kimberly K; Podany, Anthony T; Winchester, Lee C; Back, David J; Khoo, Saye H; Fletcher, Courtney V; Siccardi, Marco; Else, Laura J

Telmisartan reverses antiretroviral-induced adipocyte toxicity and insulin resistance in vitro

体外实验表明,替米沙坦可逆转抗逆转录病毒药物诱导的脂肪细胞毒性和胰岛素抵抗。

Pushpakom, Sudeep P; Adaikalakoteswari, Antonysunil; Owen, Andrew; Back, David J; Tripathi, Gyanendra; Kumar, Sudhesh; McTernan, Philip; Pirmohamed, Munir

Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection

开发药物相互作用的证据评估和综合系统,并将其应用于艾滋病毒和疟疾合并感染的系统评价

Seden, Kay; Gibbons, Sara; Marzolini, Catia; Schapiro, Jonathan M; Burger, David M; Back, David J; Khoo, Saye H

Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks

左炔诺孕酮避孕植入剂与依非韦伦类抗逆转录病毒疗法联合使用时观察到的意外妊娠:一项为期 48 周的三组药代动力学评估

Scarsi, Kimberly K; Darin, Kristin M; Nakalema, Shadia; Back, David J; Byakika-Kibwika, Pauline; Else, Laura J; Dilly Penchala, Sujan; Buzibye, Allan; Cohn, Susan E; Merry, Concepta; Lamorde, Mohammed

Distinct Pharmacodynamic Activity of Rilpivirine in Ectocervical and Colonic Explant Tissue

利匹韦林在宫颈外组织和结肠外植体组织中表现出独特的药效学活性

Dezzutti, Charlene S; Else, Laura J; Yandura, Sarah E; Shetler, Cory; Russo, Julie; Back, David J; McGowan, Ian

Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro

利匹韦林在体外抑制药物转运蛋白ABCB1、SLC22A1和SLC22A2

Moss, Darren M; Liptrott, Neill J; Curley, Paul; Siccardi, Marco; Back, David J; Owen, Andrew